MAPT and amyloidosis: The association between mutations in the MAPT gene and development of fronto-temporal dementia with Parkinsonism-linked to chromosome 17 (FTLD-17) has paved the way for dysfunctional Tau, being considered sufficient for causing neurodegeneration and dementia even in absence of amyloid pathology.